hair loss with glp-1 reported during therapy is most commonly explained by telogen effluvium, a delayed response to rapid weight loss and undernutrition., ‌, Two key contributors I assess clinically:, The risk of hair loss

Related reading Get your supplies CE-marked syringes and alcohol prep pads

While the journey to a complete cure continues, there is hope on the horizon, and the collaborative efforts of experts in the field bring us closer to a future where FIP is no longer a devastating threat to our beloved feline companions.

GLP-1 receptor agonists have also shown success in other therapeutic areas apart from type 2 diabetes and obesity, in particular for non-alcoholic fatty liver disease [104]

If you look closely at the bottom panels of the 2 graphs above for loss of body weight, the participants in the new trial had 40% less weight loss than in the previous trial of obese, non-diabetic participants